Volume Optimisation and Cognitive Function in Major Abdominal Surgery
Cognitive Decline

About this trial
This is an interventional prevention trial for Cognitive Decline focused on measuring cognitive decline, hemodynamic monitoring, LIDCO, INVOS, BIS, brain injury biomarkers
Eligibility Criteria
Inclusion Criteria:
- ASA 2-3 patients,
- > 18 years
- signed written consent for anesthesia and study participation
- Major abdominal surgery (stomach and intestin resection)
- epidural catheter insertion
Exclusion Criteria:
- pregnant women
Sites / Locations
- University Medical Centre
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
multimodal monitoring
placebo
LiDCO Rapid, unilateral INVOS and unilateral BIS monitors will be applied. Should there be pre-existing carotid stenosis, INVOS sensor will be applied on the same side. In case of pre-existing cerebral pathology, the INVOS sensor will be applied to the contralateral side. Baseline values of nominal stroke index (SI), cardiac index (CI), BIS, mean arterial pressure (MAP) and regional oxygen saturation (rSO2) will be recorded. Basal rSO2 will be recorded prior to preoxygenation which raises the value. Before the induction, up to 250ml of balanced crystalloid solution will be administered. These will include antibiotics solvents and other pre-induction i.v. therapy.
No multimodal monitoring will be applied in control group.